Journal
CURRENT MEDICINAL CHEMISTRY
Volume 13, Issue 1, Pages 109-116Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/092986706775197962
Keywords
voglibose; glucosidase inhibitor; preparation; NIDDM
Ask authors/readers for more resources
The number of people with diabetes is expected to rise from the current estimated 150 million to 220 million in 2010 and 300 million in 2025, and 90% is Type 2 diabetes or non-insulin dependant diabetes mellitus (NIDDM). Voglibose, one of the most important alpha-glucosidase inhibitors, delays the digestion and absorption of carbohydrates, thereby inhibiting postprandial hyperglycemia and hyperinsulinemia, and is the aid in the treatment of diabetes. In this paper, properties and the preparation of voglibose are reviewed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available